Just as a bit of side interest Dr Andrew Kao, MD Mid America Heart Institute, Saint Luke's Hospital who impressed me as a passionate supporter of C-Pulse at the TCT a couple of years ago is also listed as a Principal Investigator in the MYDICAR Trial. Don't know his position on MYDICAR but certainly know his position on C-Pulse.
Celladon is around $10 in-between its 52wk high ~$17 and 52wk low ~$7.50
Even if successful in their trial they would have to prove to the FDA that they can manufacture and distribute in the quantities necessary. It would seem to me a massive job to ensure every dose is the same and in pristine condition at every hospital it is to be given at with such an ethereal high tech product?
C-Pulse manufactured with existing tested technology and materials, shelf life eternity.
- Forums
- ASX - By Stock
- SHC
- Oh dear !!
Oh dear !!, page-49
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm